Site content: Global

Publications

Publications

Breast Cancer

Reduzzi et al, Crit Rev Oncol Hematol 2024

Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors

Andresen et al, Molecular Oncology 2024

Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors– a biomarker analysis of the ALICE and ICON trials

Fehm et al, Clin Chem 2024

Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells-The DETECT III Clinical Trial

Bidard et al, J Clin Oncol 2023

Overall Survival With Circulating Tumor Cell Count-Driven Choice of Therapy in Advanced Breast Cancer: A Randomized Trial

Stergiopoulou et al, Sci Rep 2023

Comprehensive liquid biopsy analysis as a tool for the early detection of minimal residual disease in breast cancer

Nanou et al, JCO Precis Oncol 2023

Tumor-Derived Extracellular Vesicles as Complementary Prognostic Factors to Circulating Tumor Cells in Metastatic Breast Cancer

Rothè et al, NPJ Breast Cancer 2022

Interrogating breast cancer heterogeneity using single and pooled circulating tumor cell analysis

Paoletti et al, NPJ Breast Cancer 2021

Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients

Müller et al, ESMO Open 2021

Prognostic relevance of the her2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program

Cabel et al, British Journal of Cancer 2021

Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial

Bidard et al, JAMA Oncology 2021

Efficacy of Circulating Tumor Cell Count-Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: The STIC CTC Randomized Clinical Trial

Darga et al, PLoS One 2021

PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancer

Silveira et al, NPJ Breast Cancer 2021

Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer

Malani et al, J Neurooncol. 2020

Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer

Krawczyk et al, BMC Cancer 2019

Determination of the androgen receptor status of circulating tumour cells in metastatic breast cancer patients

Cristofanilli et al, Critical Reviews in Oncology/Hematology 2019

The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper

Trapp et al, J Natl Cancer Inst 2019

Presence of circulating tumor cells in high-risk early breast cancer during follow-up and prognosis

Liu et al, Cancer Manag Res 2019

First-Line Doublet Chemotherapy for Metastatic Triple-Negative Breast Cancer: Circulating Tumor Cell Analysis of the tnAcity Trial

Zhong et al, Eur J Cancer 2019

Association of clinical outcomes in metastatic breast cancer patients with circulating tumor cell and circulating cell-free DNA

Sparano et al, JAMA Oncol 2018

Association of circulating tumor cells with late recurrence of estrogen receptor-positive breast cancer: a secondary analysis of a randomized clinical trial

Goodman et al, JAMA Oncol. 2018

Association of Circulating Tumor Cell Status with Benefit of radiotherapy and survival in early-stage breast cancer

Bidard et al, J Natl Cancer Inst 2018

Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: a Meta-analysis

Paoletti et al, Cancer Research 2018

Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance Mechanisms

Riethdorf et al, Clin Cancer Res 2017

Prognostic impact of circulating tumor cells for breast cancer patients treated in the neoadjuvant "Geparquattro" trial

Janni et al, Clinical Cancer Research 2016

Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer

Bidard et al, Lancet Oncol 2014

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

Cristofanilli et al, N Engl J Med 2004

Circulating tumor cells, disease progression, and survival in metastatic breast cancer